The UK Alzheimer’s disease drugs market was valued at $401 Mn in 2022 and is estimated to expand at a CAGR of 6.42% from 2022-30 and will reach $660 Mn in 2030. One of the main reasons propelling the growth of this market is the introduction of newer technologies, and the aging population. The market is segmented by drug classes and by Distribution Channels. Some key players in this market are AbbVie, AstraZeneca, Accord Healthcare, Aesica Queenborough, Allen & Hanburys, Biogen, Daiichi Sankyo Company, Eisai Co., Eli Lilly and Company, Johnson and Johnson, H. Lundbeck A/S, F. Hoffmann-La Roche AG, Merck & Co., Novartis AG, Ono Pharmaceutical Co., Pfizer and Teva Pharmaceutical among others.
By 2030, it is anticipated that the UK infectious disease therapeutics market will reach a value of $3.75 Bn from $3.12 Bn in 2022, growing at a CAGR of 2.4% during 2022-2030. Infectious Disease Therapeutics in the UK is dominated by a few domestic pharmaceutical companies such as GlaxoSmithKline, Faron Pharmaceuticals and Emergent BioSolutions. The infectious disease therapeutics market in the UK is segmented into different therapeutic areas and different treatment types. The major factors affecting the UK infectious disease therapeutics market are the increasing disease burden of communicable diseases like TB, hepatitis, and COVID-19 and the lack of healthcare funding for infectious disease treatment in various areas of the UK.
The UK Clinical Diagnostic market was valued at $1.79 Bn in 2022 and is estimated to expand at a CAGR of 4% from 2022-30 and will reach $2.45 Bn in 2030. One of the main reasons propelling the growth of this market is an increase in chronic disease and government support. The market is segmented by type, drug, and distribution channel. Some key players in this market are Abbott, Omega Diagnostics, Quest Diagnostics, F. Hoffmann-La Roche, LumiraDx, Diagnostics.ai, Thermo Fisher Scientific, Danaher Corporation, and others.
As Acne vulgaris continues to affect almost 34% of adults in the UK, the UK acne therapeutics market is expected to grow from $261 Mn in 2022 to $377 Mn in 2030 with a CAGR of 4.7% for the year 2022-2030. Revolutionary acne therapeutics options and acne awareness campaigns in the UK are responsible for the growth of the UK acne therapeutics market. The market is segmented by treatment, route of administration, age group, and by distribution channel. Chugai, Chatfield, and Takeda are some of the key competitors in the UK acne therapeutics market.
The UK Artificial Intelligence (AI) in the diagnostics market is projected to grow from $0.03 Bn in 2022 to $0.25 Bn by 2030, registering a CAGR of 33% during the forecast period of 2022 - 2030. The market will be driven by the advancing government initiatives to support the adoption of AI technology & the rising rate of chronic illnesses. The market is segmented by component & by diagnosis. Some of the major players include GE Healthcare, IBM Watson Health & Brainomix Limited.
The UK Rheumatology Drugs Market is projected to grow from $1.587 Bn in 2022 to $1.692 Bn by 2030, registering a CAGR of 0.8% during the forecast period of 2022 - 2030. Because of the high prevalence of rheumatic diseases in the nation and the availability of a top-notch healthcare system there, the market in the UK is predicted to have minimal growth over the next five years. The key players in the UK rheumatology drugs market include Pfizer, Roche, AbbVie, Merck & Co., Eli Lilly, and Company, AstraZeneca, Novartis
The UK Palliative care market is projected to grow from $340.08 Mn in 2022 to $542.04 Mn by 2030, registering a CAGR of 6% during the forecast period of 2022 - 2030. The main factors driving the growth would be the increasing prevalence of chronic diseases, increased focus on end-of-life care, government initiatives, and technological advancements. The market is segmented by service type and by the end user. Some of the major players include Everycare, Bupa, Helping Hands Homecare, Trinity Hospice, St Wilfrid's Hospice, and Home Instead.
The UK Cancer Pain Management market is projected to grow from $169.52 Mn in 2022 to $219.8 Mn by 2030, registering a CAGR of 3.3% during the forecast period of 2022 - 2030. The main factors driving the growth would be the aging population, the rise in cancer diagnoses, and greater access to cancer screening and early detection techniques. The market is segmented by drug type and by disease. Some of the major players include Napp Pharmaceuticals (GBR), GW Pharmaceuticals (GBR), Grunenthal Pharma, Hisamitsu Pharmaceutical, Pfizer, and Teva Pharmaceuticals.
The UK Orphan Diseases Drugs Market is projected to grow from $4.025 Bn in 2022 to $7.617 Bn by 2030, registering a CAGR of 8.30% during the forecast period of 2022 – 2030. There are an estimated 3 Mn people in the UK living with a rare disease, which is equivalent to around 5% of the population. Key players in the UK orphan drug market include Sanofi, Pfizer, and GlaxoSmithKline.
The UK Lung Cancer Drug Market is projected to grow from $249 Mn in 2022 to $405 Mn by 2030, registering a CAGR of 6.3% during the forecast period of 2022 - 2030. The number of new lung cancer cases diagnosed in the UK is rising, leading to a growing market for lung cancer drugs. AstraZeneca has a strong presence in the UK lung cancer drug market with its drug Tagrisso (osimertinib) which is used to treat certain types of non-small cell lung cancer (NSCLC).
This report presents a strategic analysis of the UK Anti-Aging Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the UK Anti-Aging Drugs Market , offering unmatched value, accuracy, and expert insights.
By 2030, it is anticipated that the UK oncology drugs market will reach a value of $10.6 Bn from $5.1 Bn in 2022, growing at a CAGR of 9.6% during 2022-2030. The companies operating in the oncology drug in the UK market are Immunocore, Adaptimmune, and Oxford BioMedica. The UK oncology drugs market is segmented on the basis of therapy modality and types of cancer. The market is influenced by the National Health Service (NHS) which is responsible for the majority of cancer drug spending in the UK.
The UK dermatology drugs Market is projected to grow from $442 Mn in 2022 to $868 Mn by 2030, registering a CAGR of 8.8% during the forecast period of 2022-2030. The UK dermatology drugs market is segmented by disease, drug class, and route of administration. A number of factors, such as the increasing prevalence of skin conditions, the rising demand for cosmetic procedures in the UK, and the availability of novel and cutting-edge therapies, are driving the market. The leading businesses in the UK dermatology drugs Market include Unilever and Sanofi, to name a few.
This report presents a strategic analysis of the UK Blockchain Technology in Healthcare Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the UK Blockchain Technology in Healthcare Market, offering unmatched value, accuracy and expert insights.
This report presents a strategic analysis of the UK eHealth Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the UK eHealth Market, offering unmatched value, accuracy and expert insights.
This report presents a strategic analysis of the UK Medical and Diagnostic Laboratory Service Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the UK Medical and Diagnostic Laboratory Service Market, offering unmatched value, accuracy and expert insights.
This report presents a strategic analysis of the UK Women Health Diagnostic Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the UK Women Health Diagnostic Market, offering unmatched value, accuracy and expert insights.
This report presents a strategic analysis of the UK Cardiac Surgery Instruments Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the UK Cardiac Surgery Instruments Market, offering unmatched value, accuracy and expert insights.
This report presents a strategic analysis of the UK Cardiac Monitoring Devices Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the UK Cardiac Monitoring Devices Market, offering unmatched value, accuracy and expert insights.
This report presents a strategic analysis of the UK Antiviral Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the UK Antiviral Drugs Market, offering unmatched value, accuracy and expert insights.
This report presents a strategic analysis of the UK Insulin Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the UK Insulin Market, offering unmatched value, accuracy and expert insights.
This report presents a strategic analysis of the UK Liver Disease Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the UK Liver Disease Drugs Market, offering unmatched value, accuracy and expert insights.
This report presents a strategic analysis of the UK Neurology Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the UK Neurology Drugs Market, offering unmatched value, accuracy and expert insights.
This report presents a strategic analysis of the UK Pharmaceutical Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the UK Pharmaceutical Market, offering unmatched value, accuracy and expert insights.
This report presents a strategic analysis of the UK Skin Antiseptic Products Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the UK Skin Antiseptic Products Market, offering unmatched value, accuracy and expert insights.